AP645A - Benzamine derivative, compositions containing said derivative and use thereof. - Google Patents

Benzamine derivative, compositions containing said derivative and use thereof. Download PDF

Info

Publication number
AP645A
AP645A APAP/P/1996/000866A AP9600866A AP645A AP 645 A AP645 A AP 645A AP 9600866 A AP9600866 A AP 9600866A AP 645 A AP645 A AP 645A
Authority
AP
ARIPO
Prior art keywords
compound
formula
agent
symbol
remaining symbols
Prior art date
Application number
APAP/P/1996/000866A
Other languages
English (en)
Other versions
AP9600866A0 (en
Inventor
Jean-Francois Rossignol
Original Assignee
Romark Laboratories Lc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27397680&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP645(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/227,033 external-priority patent/US5387598A/en
Priority claimed from US08/301,407 external-priority patent/US5578621A/en
Application filed by Romark Laboratories Lc filed Critical Romark Laboratories Lc
Publication of AP9600866A0 publication Critical patent/AP9600866A0/xx
Application granted granted Critical
Publication of AP645A publication Critical patent/AP645A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/58Nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/4261,3-Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
APAP/P/1996/000866A 1994-04-13 1995-04-11 Benzamine derivative, compositions containing said derivative and use thereof. AP645A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/227,033 US5387598A (en) 1994-04-13 1994-04-13 Composition and galenic formulation suitable for combatting affections of the lower abdomen
US08/301,407 US5578621A (en) 1994-09-08 1994-09-08 Benzamide derivatives
US38385595A 1995-02-06 1995-02-06
PCT/EP1995/001334 WO1995028393A1 (en) 1994-04-13 1995-04-11 Benzamide derivative, compositions containing said derivative and use thereof

Publications (2)

Publication Number Publication Date
AP9600866A0 AP9600866A0 (en) 1996-10-31
AP645A true AP645A (en) 1998-04-24

Family

ID=27397680

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1996/000866A AP645A (en) 1994-04-13 1995-04-11 Benzamine derivative, compositions containing said derivative and use thereof.

Country Status (24)

Country Link
EP (1) EP0755386B1 (de)
JP (1) JP3224395B2 (de)
KR (2) KR100348440B1 (de)
CN (1) CN1072654C (de)
AP (1) AP645A (de)
AT (1) ATE218557T1 (de)
AU (1) AU689582B2 (de)
BG (1) BG62932B1 (de)
BR (1) BR9507371A (de)
CA (1) CA2187110C (de)
CZ (1) CZ287002B6 (de)
DE (1) DE69526936T2 (de)
DK (1) DK0755386T3 (de)
ES (1) ES2161201T3 (de)
FI (1) FI120258B (de)
HU (1) HUT77404A (de)
NZ (1) NZ284800A (de)
OA (1) OA10463A (de)
PL (1) PL186504B1 (de)
PT (1) PT755386E (de)
RU (1) RU2140915C1 (de)
SI (1) SI0755386T1 (de)
SK (1) SK281949B6 (de)
WO (1) WO1995028393A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968961A (en) 1997-05-07 1999-10-19 Romark Laboratories, L.C. Pharmaceutical compositions of tizoxanide and nitazoxanide
US5856348A (en) * 1994-09-08 1999-01-05 Romark Laboratories, L.C. Method for treatment of trematodes with pharmaceutical compositions of tizoxanide and nitazoxanide
CA2467321A1 (en) 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
CA2574282A1 (en) 2004-07-21 2006-03-02 Dana-Farber Cancer Institute, Inc. Lentiviral vectors and uses thereof
UA90864C2 (en) * 2004-09-09 2010-06-10 Ромарк Лебораториз, Л.К. Halogenated benzamide derivatives
US8633230B2 (en) 2006-01-09 2014-01-21 Jean-Francois Rossignol Viral hepatitis treatment
BRPI0815057B8 (pt) 2007-08-03 2021-05-25 Romark Laboratories Lc composto, composição farmacêutica, e, uso de um composto
AP3074A (en) 2009-05-12 2014-12-31 Romark Lab Lc Haloalkyl heteroaryl benzamide compounds
JP5932640B2 (ja) * 2009-06-26 2016-06-08 ロマーク ラボラトリーズ エル.シー. インフルエンザを治療するための化合物および方法
CA2778182C (en) 2009-10-22 2018-04-17 Thomas Julius Borody Novel parasite therapy
CN104094927B (zh) * 2013-04-02 2016-06-01 兴邦(武汉)生物科技有限公司 一种处理植物的助剂组合物
TW201630606A (zh) * 2015-01-21 2016-09-01 諾華公司 包含局部藥物之蓋崙(galenic)調配物
WO2019148291A1 (en) 2018-02-02 2019-08-08 Interface Biologics, Inc. Ocular inserts comprising a covalently linked steroid dimer
WO2021220061A2 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders
EP4337200A1 (de) * 2021-05-28 2024-03-20 Henderson, Theodore Behandlung mit einer antiviralen verbindung und nitazoxanid

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1306603A (fr) * 1958-08-14 1962-10-19 Innothera Lab Sa Dérivés thiazoliques et leur procédé de préparation
FR716M (de) * 1960-08-05 1961-08-07
GB1437800A (en) * 1973-08-08 1976-06-03 Phavic Sprl Derivatives of 2-benzamido-5-nitro-thiazoles
FR2435905A1 (fr) * 1978-09-13 1980-04-11 Anvar Nouveaux agents molluscicides derives du benzamido-2 nitro-5 thiazole
US4315018A (en) * 1978-12-07 1982-02-09 Rossignol Jean F Specific parasiticidal use of 2-benzamido-5-nitro-thiazole derivatives
US4447414A (en) * 1982-12-21 1984-05-08 Cutter Laboratories, Inc. Carnivore anthelmintics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY V. 12, N. 3, PP.353-6 (SEP 1977) *

Also Published As

Publication number Publication date
EP0755386B1 (de) 2002-06-05
CZ295996A3 (en) 1997-03-12
ES2161201T3 (es) 2002-12-01
FI964031A (fi) 1996-10-08
BG62932B1 (bg) 2000-11-30
DK0755386T3 (da) 2002-08-26
DE69526936T2 (de) 2003-02-20
FI964031A0 (fi) 1996-10-08
JPH09511997A (ja) 1997-12-02
KR100348440B1 (ko) 2002-11-29
CZ287002B6 (en) 2000-08-16
CA2187110A1 (en) 1995-10-26
AU2344095A (en) 1995-11-10
HU9602798D0 (en) 1996-12-30
OA10463A (en) 2002-04-03
KR100373081B1 (ko) 2003-02-25
EP0755386A1 (de) 1997-01-29
NZ284800A (en) 1998-02-26
RU2140915C1 (ru) 1999-11-10
AP9600866A0 (en) 1996-10-31
WO1995028393A1 (en) 1995-10-26
JP3224395B2 (ja) 2001-10-29
ES2161201T1 (es) 2001-12-01
HUT77404A (hu) 1998-04-28
SI0755386T1 (en) 2002-10-31
SK130796A3 (en) 1997-06-04
CA2187110C (en) 2002-03-19
PL186504B1 (pl) 2004-01-30
BG100884A (en) 1997-07-31
CN1145621A (zh) 1997-03-19
PT755386E (pt) 2002-11-29
SK281949B6 (sk) 2001-09-11
FI120258B (fi) 2009-08-31
DE69526936D1 (de) 2002-07-11
ATE218557T1 (de) 2002-06-15
CN1072654C (zh) 2001-10-10
BR9507371A (pt) 1997-09-23
PL316757A1 (en) 1997-02-03
AU689582B2 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
AP645A (en) Benzamine derivative, compositions containing said derivative and use thereof.
MXPA96004483A (en) Derivatives of benzamide, compositions that contain such derivative and use of the mis
KR100412298B1 (ko) 콜로이드이산화규소를함유하는발라시클로비르정제
US6020353A (en) 2-(hydroxy)-N-(5-nitro-2-thiazolyl) benzamide
WO2002055067A2 (de) Fumarsäurederivate als nf-kappab-inhibitor
AU5737899A (en) The use of fumaric acid derivatives in transplant medicine
US5387598A (en) Composition and galenic formulation suitable for combatting affections of the lower abdomen
WO2001045712A1 (de) Arzneimittelkombinationen gegen virale erkrankungen
US20180021339A1 (en) Method for treating liver diseases of various origins
SK50696A3 (en) Flavin and its derivatives as anti-viral agents
RO118293B1 (ro) Derivat de benzamida, compozitii continand acest derivat si utilizarea acestuia
WO2022211303A1 (ko) 3-(4-(벤질옥시)페닐)헥스-4-이노익산 유도체의 신규 용도
MXPA00010855A (es) Uso de derivados de benzamida como agentes parasitarios, antibacterianos, antivirales y antifungicos
JPH09508150A (ja) B型肝炎の予防または治療のためのチオケテン誘導体の用途
CZ2020210A3 (cs) Léková forma s obsahem chininu a jeho solí pro perorální aplikaci
CZ329091A3 (cs) Léková forma s obsahem chininu nebo jeho solí pro perorální aplikaci
DE3833392A1 (de) Verwendung von pyrimido(5,4-d)pyrimidinen zur verhinderung der primaeren und sekundaeren resistenz bei der chemotherapie und diese verbindungen enthaltende arzneimittel
Nwankwo et al. Liver and Kidney Function Tests and Histological Study on Malaria Parasite Infected Mice Administered with Seed Extract of Picralima nitida
DE10012259A1 (de) Arzneimittelkombination gegen virale Erkrankungen
JPH02149524A (ja) ひと免疫不全ウイルス性疾患処置剤